(Q37811071)

23 August 2017

title

Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis (English)

1 reference

23 August 2017

0 references

0 references

Leon A Adams

1

1 reference

23 August 2017

Ariel E Feldstein

series ordinal

2

1 reference

23 August 2017

language of work or name

1 reference

1 February 2011

1 reference

Journal of Digestive Diseases

23 August 2017

published in

1 reference

23 August 2017

volume

12

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

10-16

1 reference

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Noninvasive assessment of hepatic steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Silent non-alcoholic fatty liver disease-a clinical-histological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Pathogenesis of non-alcoholic steatohepatitis: human data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

Nonalcoholic Fatty Liver Disease in Severely Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00471.X

10.1111/J.1751-2980.2010.00471.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference